BMS positioned to lead in the multiple myeloma market
BMS’ acquisition strategy has led to a significant expansion of its IO portfolio, placing the company a step ahead of the competition. Credit: David A. Litman on Shutterstock.
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.ContinueLearn more